New OTC Nexium approved

Share this article:

Pfizer's consumer portfolio now includes a 24-hour version of over-the-counter Nexium. The company announced Friday that the FDA greenlighted the no-prescription heartburn medication.

The company is also pursuing an OTC version of its former prescription blockbuster cholesterol medication Lipitor.

Pfizer acquired worldwide marketing rights to the non-Rx version of AZ's blockbuster proton-pump inhibitor in 2012. Deal terms called for a $250-million upfront payment.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions